Gygi S P, Wilkins D G, Rollins D E
Department of Pharmacology and Toxicology, University of Utah, Salt Lake City 84112, USA.
J Anal Toxicol. 1995 Oct;19(6):387-91. doi: 10.1093/jat/19.6.387.
Hair analysis for drugs of abuse provides a possible long-term measure of drug use not possible with urinalysis. Many drugs and their metabolites have been detected in hair; however, the factors influencing the incorporation of chemicals into hair are poorly understood. An animal model for chemical uptake into hair utilizing controlled drug administration was developed to ascertain if increasing doses of codeine are reflected in the concentrations of codeine and its metabolites found in hair. Male Sprague-Dawley rats were administered codeine at 5, 10, or 20 mg/kg (intraperitoneally; n = 6) daily for 21 days. At various times during and after the dosing protocol, approximately 50 mg of hair was shaved from a different area of the animals' backs and analyzed for codeine and morphine concentrations by ion-trap gas chromatography-mass spectrometry. Peak hair codeine concentrations for the 5-, 10-, and 20-mg/kg groups occurred 20 days after beginning the dosing protocol and were 0.57 +/- 0.13, 0.80 +/- 0.10, and 1.95 +/- 0.35 ng/mg hair, respectively. Morphine peak concentrations occurred at the same time and were 1.08 +/- 0.28, 1.21 +/- 0.09, and 2.10 +/- 0.26 ng/mg hair for the 5-, 10-, and 20-mg/kg groups, respectively. Long-term dosing in the rat resulted in similar or greater hair concentrations of morphine (metabolite) than codeine. The plasma pharmacokinetics of codeine and morphine were also obtained after a single, intraperitoneal codeine administration of 20 mg/kg. An experiment involving washing the rat hair with methanol or phosphate buffer (pH 9.0) did not reduce the concentration of codeine or morphine measured in hair as compared with nonwashed control hair. Data obtained in this study indicate that after controlled administration the incorporation of codeine and its metabolite, morphine, into rat hair occurs in a distinct dose-proportional manner.
对滥用药物进行毛发分析提供了一种检测药物使用情况的长期手段,而尿液分析则无法做到这一点。人们已在毛发中检测出多种药物及其代谢物;然而,对于影响化学物质进入毛发的因素,我们却知之甚少。为了确定增加可待因剂量是否会反映在毛发中可待因及其代谢物的浓度上,我们开发了一种利用受控药物给药来研究化学物质进入毛发情况的动物模型。将雄性斯普拉格-道利大鼠每天腹腔注射5、10或20毫克/千克的可待因(每组n = 6),持续21天。在给药方案期间及之后的不同时间,从动物背部的不同区域剃下约50毫克毛发,并用离子阱气相色谱-质谱法分析可待因和吗啡的浓度。5毫克/千克、10毫克/千克和20毫克/千克组毛发中可待因的峰值浓度在给药方案开始20天后出现,分别为0.57±0.13、0.80±0.10和1.95±0.35纳克/毫克毛发。吗啡的峰值浓度在同一时间出现,5毫克/千克、10毫克/千克和20毫克/千克组分别为1.08±0.28、1.21±0.09和2.10±0.26纳克/毫克毛发。在大鼠中长期给药后,毛发中吗啡(代谢物)的浓度与可待因相似或更高。在单次腹腔注射20毫克/千克可待因后,还获得了可待因和吗啡的血浆药代动力学数据。一项用甲醇或磷酸盐缓冲液(pH 9.0)清洗大鼠毛发的实验表明,与未清洗的对照毛发相比,清洗后毛发中可待因或吗啡的浓度并未降低。本研究获得的数据表明,在受控给药后,可待因及其代谢物吗啡在大鼠毛发中的掺入呈明显的剂量比例关系。